Posts by Sandra Ansanay-Alex
FluoSphera expands into the testing of Antibody-Drug-Conjugates (ADCs)
FluoSphera, a Geneva-based leader in systemic drug discovery, is proud to announce its strategic expansion into the testing of Antibody-Drug-Conjugates (ADCs). By deploying new predictive tools based on its proprietary technology, FluoSphera aims to provide ‘first-in-human’ in vitro data on ADCs in development, in order to optimise their properties and increase their clinical success rate.…
Read MorePerivision VisionOne gets CE-Mark
Perivision has received the EU CE-certification for its 1st medical software product VisionOne. PeriVision, an innovative spin-off from the University of Bern and the University Hospital Bern, and now based at Biopôle in Lausanne, has received the EU CE-certification for its 1st medical software product VisionOne. VisionOne addresses the large unmet clinical need…
Read MoreLa Prairie launches the Longevity Fund
Clinique La Prairie (CLP), global leader in longevity since 1931, announces the LONGEVITY FUND, an endeavour to identify and invest in companies that revolutionize the landscape of ageing, health, and wellbeing. The Fund will focus on driving science-based advancements in longevity, guided by four core mission pillars: Medical Care, Nutrition, Movement, and Wellbeing.…
Read MoreThe Foundation for Technological Innovation (FIT) – 30 years serving entrepreneurship
The Foundation for Technological Innovation (FIT) celebrates 30 years of supporting innovation in French-speaking Switzerland Founded in 1994, the Foundation for Technological Innovation (FIT) is celebrating its 30th anniversary this year. Since its creation, this public-private organisation, whose mission is to support innovation and business start-ups in French-speaking Switzerland, has distributed more than…
Read MoreSPHN launches a new cross-hospital data query tool powered by Tune Insight
The Swiss Personalised Health Networking is introducing the SPHN Data Exploration and Analysis System (DEAS), powered by EPFL Spin-off Tune Insight. HUG, CHUV and several swiss hospitals are also part of the project. The Swiss Personalised Health Network (SPHN) is enhancing data query capabilities with the Data Exploration and Analysis System (DEAS), a robust…
Read MoreMaven Health takes part in the OH MY GUT! project
The new public-private partnership aims to explore how what we eat affects our gut health and, in turn, how our gut health impacts our stress responses. By combining the expertise of both academic researchers and industry experts, the project focuses on creating innovative dietary solutions and personalized strategies to manage stress. In our…
Read MoreDexter Surgical Robot by Distalmotion Gains FDA Approval
Distalmotion’s Dexter Surgical Robot has officially received FDA approval for use in inguinal hernia repairs, introducing a transformative solution for outpatient surgery and Ambulatory Surgery Centers (ASCs) in the U.S. Known for its compact and mobile design, Dexter is set to meet the rising demand for cost-effective, robotic-assisted surgeries in high-volume settings. Dexter,…
Read MoreAdoram Therapeutics, ex vivo and Dyneo Technologies awarded by the FIF
Three Innovative Geneva start-ups Secure FIF financing to drive technological advances in Life Sciences, Virtual Reality for Medical Education and Cleantech The selected companies, Adoram Therapeutics, Dyneo Technologies and ex vivo, have received a combined total of 250,000 CHF in FIF funding, including Seed Loans and Grants, to advance their groundbreaking technologies and solutions.…
Read MoreDuhn Therapeutics signs global license agreement with OM Pharma
Duhn Therapeutics SAS, a clinical-stage company co-founded by Landmark BioVentures AG, and OM Pharma SA, a global biopharmaceutical company and leader in bacterial lysate products, announce an exclusive licence agreement to advance the development and commercialization of lead candidate DHN198, previously OM-174, in a pipeline of lipid-based cancer immunotherapies. Duhn Therapeutics, with executive…
Read MoreONWARD Medical raises CHF 50 million
ONWARD Medical N.V.announces that it successfully raised an amount of EUR 50 million led by a cornerstone investment from Ottobock, a German global leader in prosthetics, orthotics, and exoskeleton technology. The investment is extending the company’s cash runway to two years or more, providing ample capital to fuel its transition to a commercial enterprise, and…
Read More